UNITY BIOTECHNOLOGY INC's ticker is UBX and the CUSIP is 91381U101. A total of 88 filers reported holding UNITY BIOTECHNOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $19,000 | -26.9% | 45,951 | 0.0% | 0.00% | – |
Q2 2022 | $26,000 | +36.8% | 45,951 | +264.9% | 0.00% | – |
Q4 2021 | $19,000 | -50.0% | 12,594 | 0.0% | 0.00% | – |
Q3 2021 | $38,000 | -94.3% | 12,594 | -91.2% | 0.00% | – |
Q2 2021 | $667,000 | -50.9% | 143,577 | -36.6% | 0.00% | – |
Q1 2021 | $1,359,000 | +18.4% | 226,402 | +3.4% | 0.00% | – |
Q4 2020 | $1,148,000 | +58.1% | 218,966 | +4.4% | 0.00% | – |
Q3 2020 | $726,000 | -55.6% | 209,782 | +11.4% | 0.00% | -100.0% |
Q2 2020 | $1,635,000 | +68.2% | 188,359 | +12.5% | 0.00% | 0.0% |
Q1 2020 | $972,000 | -14.4% | 167,414 | +6.4% | 0.00% | 0.0% |
Q4 2019 | $1,135,000 | +23.5% | 157,403 | +4.6% | 0.00% | 0.0% |
Q3 2019 | $919,000 | +40.1% | 150,502 | +118.2% | 0.00% | – |
Q2 2019 | $656,000 | +31.5% | 68,983 | +12.1% | 0.00% | – |
Q1 2019 | $499,000 | -49.8% | 61,520 | +0.6% | 0.00% | -100.0% |
Q4 2018 | $994,000 | +167.9% | 61,125 | +169.0% | 0.00% | – |
Q3 2018 | $371,000 | +20.1% | 22,725 | +11.0% | 0.00% | – |
Q2 2018 | $309,000 | – | 20,480 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Mayo Clinic | 1,571,981 | $8,237,000 | 9.91% |
Invus Financial Advisors, LLC | 1,094,998 | $5,738,000 | 2.40% |
Founders Fund V Management, LLC | 491,751 | $2,577,000 | 0.66% |
ALGERT GLOBAL LLC | 51,890 | $272,000 | 0.08% |
Arbor Wealth Management, LLC | 25,888 | $136,000 | 0.05% |
Moloney Securities Asset Management, LLC | 41,950 | $220,000 | 0.05% |
PDT Partners, LLC | 78,800 | $413,000 | 0.03% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 394,957 | $2,070,000 | 0.02% |
Fort Point Capital Partners LLC | 10,000 | $52,000 | 0.01% |
Baillie Gifford | 3,803,014 | $19,928,000 | 0.01% |